Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|May 6, 2022
Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab AntibodiesJennifer R Blase, David Frame, Thomas F Michniacki, et al.Current Opinion in Rheumatology|March 20, 2021
The use of mycophenolate mofetil area under the curveKatherine Chakrabarti, David Frame, Mousa Al Abbas, et al.JAMA|October 20, 2005
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestryRita Nanda, L Philip Schumm, Shelly Cummings, et al.Journal of Pediatric Hematology/Oncology|May 25, 2017
Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the LiteratureLydia L Benitez, Katherine Gharibian, David Frame, et al.The Breast Journal|October 23, 2002
Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient ageAmila Orucevic, Vijaya B Reddy, Kenneth J Bloom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancerNicholas Robert, Brian Leyland-Jones, Lina Asmar, et al.Cancer Reports (Hoboken, N.J.)|September 4, 2020
Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic centerElizabeth Elliott, Virginia Speare, James Coggan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERsSara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2019
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERsMelody Cobleigh, Denise A Yardley, Adam M Brufsky, et al.The Oncologist|February 12, 2020
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs RegistryDebu Tripathy, Adam Brufsky, Melody Cobleigh, et al.Pageof 5